Basics CRISPR Therapeutics AG CRISPR Therapeutics AG is a gene editing company. It is engaged in the development of CRISPR/Cas9-based therapeutics. IPO Date: October 19, 2016 Sector: Healthcare Industry: Biotech Market Cap: $5.42B Activated in VL: True Average Daily Range Avg Daily Range: $1.62 | 2.81% Avg Daily Range (30 D): $1.75 | 3.17% Avg Daily Range (90 D): $1.71 | 2.85% Institutional Daily Volume Avg Daily Volume: 1.19M Avg Daily Volume (30 D): 2.16M Avg Daily Volume (90 D): 2.28M Trade Size Avg Trade Size (Sh.): 63 Avg Trade Size (Sh.) (30 D): 51 Avg Trade Size (Sh.) (90 D): 53 Institutional Trades Total Inst.Trades: 5,929 Avg Inst. Trade: $2.95M Avg Inst. Trade (30 D): $3.19M Avg Inst. Trade (90 D): $4.24M Avg Inst. Trade Volume: .05M Avg Inst. Trades (Per Day): 3 Market Closing Trades Avg Closing Trade: $5.5M Avg Closing Trade (30 D): $9.77M Avg Closing Trade (90 D): $12.3M Avg Closing Volume: 86.3K     News Dec 7, 2025 @ 2:25 PM 2 Stocks That Could Soar by 52% and 282%, Accordin... Source: Prosper Junior Bakiny Nov 30, 2025 @ 9:10 AM Meet the Beaten-Down Biotech Stock Cathie Wood Lov... Source: Adria Cimino Nov 29, 2025 @ 6:23 PM The Best Stocks to Buy With $1,000 Right Now Source: James Brumley Nov 19, 2025 @ 11:05 AM Missed Out on Eli Lilly? 2 Healthcare Stocks With ... Source: Adria Cimino Nov 12, 2025 @ 10:04 PM ARK Sold Almost 400,000 Shares of CRISPR Therapeut... Source: Howard Smith Financials   TTM Q2 2025 Q1 2025 Basic EPS $-1.17 $-2.4 $-1.58 Diluted EPS $-1.17 $-2.4 $-1.58 Revenue $ .89M $ .89M $ .87M Gross Profit $ $ $ Net Income / Loss $ -106.44M $ -208.55M $ -136M Operating Income / Loss $ -132.06M $ -229.32M $ -148.42M Cost of Revenue $ $ $ Net Cash Flow $ 92.91M $ -41.65M $ -63.11M PE Ratio